𝛼SK or Search

ENTITY

Lepu Biopharma (2157 HK)

70

Analysis

Health Care • China

Lepu Biopharma Co. Ltd. is an innovation-driven biopharmaceutical company focused on discovering, developing, and commercializing drug candidates in anti-tumor targeted therapy and oncology immunotherapy. The company's pipeline includes ADCs, immunotherapies, and oncolytic virus drugs, with commercial products like Puyouheng and Meiyouheng. It was founded in 2018 and is headquartered in Shanghai, China.

more

Refresh

Exchange Announcement • 23 Sep 2026 16:31

Voluntary Announcement Four Clinical Studies Selected For Presentation At 2026 Esmo Congress: Cmg901 (Azd0901) Clinical Trial Results Selected As Lba For Proffered Paper Presentation At Presidential Symposium, Mrg007 Clinical Trial Results Selected As Lba For Rapid Oral Presentation, And Two Other Studies Selected For Rapid Oral Presentation

Exchange Announcement • 16 Sep 2026 16:32

2026 Interim Report

Exchange Announcement • 19 Aug 2026 16:38

Interim Results Announcement For The Six Months Ended June 30, 2026

Exchange Announcement • 07 Aug 2026 19:04

Notice Of Board Meeting

Exchange Announcement • 28 Jul 2026 12:27

Voluntary Announcement Positive Top-Line Results Achieved From Clarity-Gastric01 Global Phase Iii Trial Of Cmg901 (Azd0901)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x